Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

The Expanding Class 2 CRISPR Toolbox: Diversity, licability, and Targeting Drawbacks

Loading...
Thumbnail Image

Authors

Hajizadeh Dastjerdi, Arash
Newman, Anthony
Burgio, Gaetan

Journal Title

Journal ISSN

Volume Title

Publisher

Adis International Ltd.

Abstract

The class 2 clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system, one of the prokaryotic adaptive immune systems, has sparked a lot of attention for its use as a gene editing tool. Currently, type II, V, and VI effector modules of this class have been characterized and extensively tested for nucleic acid editing, imaging, and disease diagnostics. Due to the unique composition of their nuclease catalytic center, the effector modules substantially vary in their function and possible biotechnology applications. In this review, we discuss the structural and functional diversity in class 2 CRISPR effectors, and debate their suitability for nucleic acid targeting and their shortcomings as gene editing tools.

Description

Keywords

Citation

Hajizadeh Dastjerdi, A., Newman, A. & Burgio, G. The Expanding Class 2 CRISPR Toolbox: Diversity, Applicability, and Targeting Drawbacks. BioDrugs 33, 503–513 (2019). https://doi.org/10.1007/s40259-019-00369-y

Source

BioDrugs

Book Title

Entity type

Access Statement

Open Access

License Rights

Restricted until

Downloads

File
Description
Author Accepted Manuscript